<code id='2DD8918C45'></code><style id='2DD8918C45'></style>
    • <acronym id='2DD8918C45'></acronym>
      <center id='2DD8918C45'><center id='2DD8918C45'><tfoot id='2DD8918C45'></tfoot></center><abbr id='2DD8918C45'><dir id='2DD8918C45'><tfoot id='2DD8918C45'></tfoot><noframes id='2DD8918C45'>

    • <optgroup id='2DD8918C45'><strike id='2DD8918C45'><sup id='2DD8918C45'></sup></strike><code id='2DD8918C45'></code></optgroup>
        1. <b id='2DD8918C45'><label id='2DD8918C45'><select id='2DD8918C45'><dt id='2DD8918C45'><span id='2DD8918C45'></span></dt></select></label></b><u id='2DD8918C45'></u>
          <i id='2DD8918C45'><strike id='2DD8918C45'><tt id='2DD8918C45'><pre id='2DD8918C45'></pre></tt></strike></i>

          fashion

          fashion

          author:knowledge    Page View:4
          George Yancopoulos on the 2024 Breakthrough Summit East stage.
          George Yancopoulos on the 2024 Breakthrough Summit East stage STAT

          George Yancopoulos is in touch with his teenage self.

          After 35 years as head scientist at Regeneron Pharmaceuticals, Yancopoulos has led the development of 12 approved medicines, turning a once-fledgling company into the $100 billion global drugmaker it is today. And you can trace a straight line back to the childhood fascination with science he fostered growing up in Woodside, Queens.

          advertisement

          “My high school science project was about regenerating neurons, and ‘Regeneron’ is a contraction of ‘regenerating neurons,’” Yancopoulos said at the STAT Summit East on Thursday. “In some ways I’m still working on my high school science project.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          FDA has safety concerns on CRISPR
          FDA has safety concerns on CRISPR

          AdobeTheFoodandDrugAdministrationsaidonFridaythatithassomesafetyconcernsaboutanexperimentalCRISPR-ba

          read more
          Peter Hotez and the public health issue of online harassment
          Peter Hotez and the public health issue of online harassment

          AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

          read more

          Maker of FluMist seeks to allow at

          ApatientreceivestheFluMistvaccineduringaclinicinSilverSpring,Md.TIMSLOAN/AFP/GettyImagesPeopleeligib